Summary

● From a short-term investment perspective, the company presents a deteriorated fundamental configuration.


Strengths

● The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.

● Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.

● Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.

● The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

● The opinion of analysts covering the stock has improved over the past four months.


Weaknesses

● The company's earnings growth outlook lacks momentum and is a weakness.

● The company is in debt and has limited leeway for investment

● The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 34.18 times its estimated earnings per share for the ongoing year.

● Based on current prices, the company has particularly high valuation levels.

● The company appears highly valued given the size of its balance sheet.

● The valuation of the company is particularly high given the cash flows generated by its activity.

● The company is not the most generous with respect to shareholders' compensation.

● For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.

● The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.

● For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.

● For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.

● Over the past four months, analysts' average price target has been revised downwards significantly.

● The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.

● The group usually releases earnings worse than estimated.